Patient Guide: A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 43 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT03633708
Status: 🟢 Enrolling Now
Condition: Secondary Hyperparathyroidism, Chronic Kidney Disease
Phase: PHASE3

Where You Can Participate

This study is available at 43 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Aurora, Colorado
  • • Kansas City, Missouri
  • • And 40 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis - Join Clinical Trial NCTNCT03633708

How to Join This Clinical Trial - NCTNCT03633708

Learn how to participate in this PHASE3 trial studying an investigational therapy for Secondary Hyperparathyroidism, Chronic Kidney Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Secondary Hyperparathyroidism, Chronic Kidney Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Secondary Hyperparathyroidism, Chronic Kidney Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT03633708 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 43 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90027 - United States

Status: RECRUITING

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: TERMINATED

Clinical Research Site

Kansas City, Missouri 64108 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10029 - United States

Status: COMPLETED

Clinical Research Site

Cincinnati, Ohio 45229 - United States

Status: COMPLETED

Clinical Research Site

Cleveland, Ohio 44195 - United States

Status: RECRUITING

Clinical Research Site

Oklahoma City, Oklahoma 73104 - United States

Status: COMPLETED

Clinical Research Site

Philadelphia, Pennsylvania 19104 - United States

Status: RECRUITING

Clinical Research Site

Dallas, Texas 75390 - United States

Status: TERMINATED

Clinical Research Site

Salt Lake City, Utah 84113 - United States

Status: RECRUITING

And 33 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Secondary Hyperparathyroidism, Chronic Kidney Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships